Phoenix Life Sciences International Ltd
Change company Symbol lookup
Select an option...
PLSI Phoenix Life Sciences International Ltd
KO Coca-Cola Co
BAC Bank of America Corp
HXL Hexcel Corp
RDHL Redhill Biopharma Ltd
WASH Washington Trust Bancorp Inc
ADC Agree Realty Corp
FB Facebook Inc
HSTM HealthStream Inc
AMZN Amazon.com Inc
Go

Company profile

Phoenix Life Sciences International Ltd, formerly MediJane Holdings, Inc., is a global healthcare solutions company. The Company is focused on advancing research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. Its pharmaceutical products contains extracts from medical cannabis, which includes medical cannabis products for doctors prescription, as well as products for the targeted treatment of specific conditions, such as diabetes and cervical cancer. Its products include Phoenix Daily, Phoenix Relax, Phoenix Sleep, Phoenix Sport Plus, Phoenix Metabolic, Phoenix Onco, Phoenix Pain, Phoenix Mood and Phoenix Neuro. Its provides its products through various forms, including soft gel, oral thin film (OTF), sublingual tablets, transdermal patches, suppository and tropical cream.

Closing Price
$7.25
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.00
Day's Low
7.25
Volume
(Light)
Volume:
301

10-day average volume:
696
301

Company Profile

Phoenix Life Sciences International Ltd, formerly MediJane Holdings, Inc., is a global healthcare solutions company. The Company is focused on advancing research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. Its pharmaceutical products contains extracts from medical cannabis, which includes medical cannabis products for doctors prescription, as well as products for the targeted treatment of specific conditions, such as diabetes and cervical cancer. Its products include Phoenix Daily, Phoenix Relax, Phoenix Sleep, Phoenix Sport Plus, Phoenix Metabolic, Phoenix Onco, Phoenix Pain, Phoenix Mood and Phoenix Neuro. Its provides its products through various forms, including soft gel, oral thin film (OTF), sublingual tablets, transdermal patches, suppository and tropical cream.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
--
Price/Book (MRQ)
34.12x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

PLSI is in a share class of common stock
Float
32.6M
Shares Outstanding
32.6M
Institutions Holding Shares
--
--

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Janelle MarsdenCEO
  • Geoff BoyntonCFO
  • Lewis A. HumerDir.

Address

  • 3000 Lawrence St
  • Denver, CO 80205-3422
  • Phone: (720) 699-7222
  • Fax: (775) 525-2898

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by , Copyright © 2019. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.